From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs
Abstract
Review1 August 2019Open Access From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs Rebecca L McIntyre Rebecca L McIntyre Laboratory Genetic Metabolic Diseases, Amsterdam UMC, Amsterdam Gastroenterology and Metabolism, Amsterdam Cardiovascular Sciences, University of Amsterdam, Amsterdam, The Netherlands Search for more papers by this author Eileen G Daniels Eileen G Daniels Laboratory Genetic...
Paper Details
Title
From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs
Published Date
Aug 1, 2019
Journal
Volume
11
Issue
9
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History